AAAAAA

   
Results: 1-22 |
Results: 22
UREMIC PRURITUS IS NOT RELATED TO BETA-ENDORPHIN SERUM LEVELS IN HEMODIALYSIS-PATIENTS
Authors: METTANG T FISCHER FP DOLLENBACHER U KUHLMAN U
Citation: T. Mettang et al., UREMIC PRURITUS IS NOT RELATED TO BETA-ENDORPHIN SERUM LEVELS IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 13(1), 1998, pp. 231-232
SEVERE THROMBOCYTOPENIA AND RESPONSE TO CORTICOSTEROIDS IN A CASE OF NEPHROPATHIA-EPIDEMICA
Authors: DUNST R METTANG T KUHLMANN U
Citation: R. Dunst et al., SEVERE THROMBOCYTOPENIA AND RESPONSE TO CORTICOSTEROIDS IN A CASE OF NEPHROPATHIA-EPIDEMICA, American journal of kidney diseases, 31(1), 1998, pp. 116-120
PLASTICIZERS IN RENAL-FAILURE - ASPECTS OF METABOLISM AND TOXICITY
Authors: METTANG T FISCHER FP DUNST R KUHLMANN U RETTENMEIER AW
Citation: T. Mettang et al., PLASTICIZERS IN RENAL-FAILURE - ASPECTS OF METABOLISM AND TOXICITY, Peritoneal dialysis international, 17, 1997, pp. 31-36
PVC-PLASTICIZER DEHP - ASPECTS OF METABOL ISM AND TOXICITY
Authors: RETTENMEIER AW METTANG T
Citation: Aw. Rettenmeier et T. Mettang, PVC-PLASTICIZER DEHP - ASPECTS OF METABOL ISM AND TOXICITY, Nieren- und Hochdruckkrankheiten, 26, 1997, pp. 2-6
PLASTICIZERS IN PATIENTS WITH END-STAGE R ENAL-FAILURE - ASPECTS OF EXPOSITION AND TOXICITY
Authors: METTANG T FISCHER FP KUHLMANN U RETTENMEIER AW
Citation: T. Mettang et al., PLASTICIZERS IN PATIENTS WITH END-STAGE R ENAL-FAILURE - ASPECTS OF EXPOSITION AND TOXICITY, Nieren- und Hochdruckkrankheiten, 26, 1997, pp. 7-12
IN-VITRO EFFECTS OF GLUCOSE POLYMER-CONTAINING PERITONEAL-DIALYSIS FLUIDS ON PHAGOCYTIC-ACTIVITY
Authors: THOMAS S SCHENK U FISCHER FP METTANG T PASSLICKDEETJEN J KUHLMANN U
Citation: S. Thomas et al., IN-VITRO EFFECTS OF GLUCOSE POLYMER-CONTAINING PERITONEAL-DIALYSIS FLUIDS ON PHAGOCYTIC-ACTIVITY, American journal of kidney diseases, 29(2), 1997, pp. 246-253
L-CARNITINE DOES NOT ALLEVIATE UREMIC PRURITUS IN HEMODIALYSIS-PATIENTS
Authors: METTANG T THOMAS S KUHLMANN U
Citation: T. Mettang et al., L-CARNITINE DOES NOT ALLEVIATE UREMIC PRURITUS IN HEMODIALYSIS-PATIENTS, Nephron, 75(3), 1997, pp. 372-372
STERNOCOSTOCLAVICULAR HYPEROSTOSIS
Authors: MAGADUM S METTANG T MEINKE J KUHLMANN U
Citation: S. Magadum et al., STERNOCOSTOCLAVICULAR HYPEROSTOSIS, Deutsche Medizinische Wochenschrift, 121(48), 1996, pp. 1492-1497
UREMIC PRURITUS - PATHOPHYSIOLOGY AND THE RAPEUTICS
Authors: METTANG T FISCHER FP KUHLMANN U
Citation: T. Mettang et al., UREMIC PRURITUS - PATHOPHYSIOLOGY AND THE RAPEUTICS, Deutsche Medizinische Wochenschrift, 121(33), 1996, pp. 1025-1031
UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS
Authors: METTANG T THOMAS S MACHLEIDT C FISCHER FP KUHLMANN U RETTENMEIER AW
Citation: T. Mettang et al., UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1213-1213
UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS
Authors: METTANG T THOMAS S KIEFER T FISCHER FP KUHLMANN U WODARZ R RETTENMEIER AW
Citation: T. Mettang et al., UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 11(12), 1996, pp. 2439-2443
THE FATE OF LEACHED DI(2-ETHYLHEXYL)PHTHALATE IN PATIENTS UNDERGOING CAPD TREATMENT
Authors: METTANG T THOMAS S KIEFER T FISCHER FP KUHLMANN U WODARZ R RETTENMEIER AW
Citation: T. Mettang et al., THE FATE OF LEACHED DI(2-ETHYLHEXYL)PHTHALATE IN PATIENTS UNDERGOING CAPD TREATMENT, Peritoneal dialysis international, 16(1), 1996, pp. 58-62
LOW-DOSE INTRADERMAL VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION IN PATIENTS WITH END-STAGE RENAL-FAILURE - A PRELIMINARY-STUDY
Authors: METTANG T SCHENK U THOMAS S MACHLEIDT C KIEFER T FISCHER FP KUHLMANN U
Citation: T. Mettang et al., LOW-DOSE INTRADERMAL VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION IN PATIENTS WITH END-STAGE RENAL-FAILURE - A PRELIMINARY-STUDY, Nephron, 72(2), 1996, pp. 192-196
PROPAFENONE IN A USUAL DOSE PRODUCES SEVERE SIDE-EFFECTS - THE IMPACTOF GENETICALLY-DETERMINED METABOLIC STATUS ON DRUG-THERAPY
Authors: MORIKE K MAGADUM S METTANG T GRIESE EU MACHLEIDT C KUHLMANN U
Citation: K. Morike et al., PROPAFENONE IN A USUAL DOSE PRODUCES SEVERE SIDE-EFFECTS - THE IMPACTOF GENETICALLY-DETERMINED METABOLIC STATUS ON DRUG-THERAPY, Journal of internal medicine, 238(5), 1995, pp. 469-472
IN-VITRO EFFECTS OF BICARBONATE-BUFFERED VERSUS LACTATE-BUFFERED CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS FLUIDS ON PERITONEAL MACROPHAGE FUNCTION
Authors: FISCHER FP SCHENK U KIEFER T HUBEL E THOMAS S YATZIDIS H METTANG T KUHLMANN U
Citation: Fp. Fischer et al., IN-VITRO EFFECTS OF BICARBONATE-BUFFERED VERSUS LACTATE-BUFFERED CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS FLUIDS ON PERITONEAL MACROPHAGE FUNCTION, American journal of kidney diseases, 26(6), 1995, pp. 924-933
IN-VITRO EFFECTS OF LOW-CALCIUM PERITONEAL-DIALYSIS SOLUTIONS ON PERITONEAL MACROPHAGE FUNCTIONS
Authors: KIEFER T SCHENK U HUBEL E WEBER J METTANG T PASSLICKDEETJEN J KUHLMANN U
Citation: T. Kiefer et al., IN-VITRO EFFECTS OF LOW-CALCIUM PERITONEAL-DIALYSIS SOLUTIONS ON PERITONEAL MACROPHAGE FUNCTIONS, American journal of kidney diseases, 25(5), 1995, pp. 751-760
INTRADERMAL (ID) VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION (HEP-B-VAC) IN PATIENTS WITH END-STAGE RENAL-FAILURE (ESRD)
Authors: METTANG T THOMAS S KIEFER T SCHENK U FISCHER FP MACHLEIDT C KUHLMANN U
Citation: T. Mettang et al., INTRADERMAL (ID) VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION (HEP-B-VAC) IN PATIENTS WITH END-STAGE RENAL-FAILURE (ESRD), Journal of the American Society of Nephrology, 5(3), 1994, pp. 338-338
THE INFLUENCE OF GLUCOSE-POLYMER (GP)-CONTAINING PERITONEAL-DIALYSIS FLUIDS (PDF) VERSUS GLUCOSE (GLU)-CONTAINING PDF ON PHAGOCYTIC CAPACITY
Authors: THOMAS S SCHENK U FISCHER FP METTANG T KUHLMANN U PASSLICKDEETJEN J
Citation: S. Thomas et al., THE INFLUENCE OF GLUCOSE-POLYMER (GP)-CONTAINING PERITONEAL-DIALYSIS FLUIDS (PDF) VERSUS GLUCOSE (GLU)-CONTAINING PDF ON PHAGOCYTIC CAPACITY, Journal of the American Society of Nephrology, 5(3), 1994, pp. 427-427
IN-VITRO EFFECTS OF AMINO-ACID-BASED VERSUS GLUCOSE-BASED CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS FLUIDS ON PERITONEAL MACROPHAGE FUNCTION
Authors: SCHENK U KIEFER T HUBEL E WEBER J METTANG T PASSLICKDEETJEN J KUHLMANN U
Citation: U. Schenk et al., IN-VITRO EFFECTS OF AMINO-ACID-BASED VERSUS GLUCOSE-BASED CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS FLUIDS ON PERITONEAL MACROPHAGE FUNCTION, Nephron, 68(3), 1994, pp. 338-346
SURVIVAL OF 138 SURGICALLY PLACED STRAIGHT DOUBLE-CUFF TENCKHOFF CATHETERS IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
Authors: WEBER J METTANG T HUBEL E KIEFER T KUHLMANN U
Citation: J. Weber et al., SURVIVAL OF 138 SURGICALLY PLACED STRAIGHT DOUBLE-CUFF TENCKHOFF CATHETERS IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Peritoneal dialysis international, 13(3), 1993, pp. 224-227
INTRADERMAL HEPATITIS-B VACCINATION IN NONRESPONSIVE HEMODIALYSIS-PATIENTS
Authors: METTANG T WEBER J SCHENK U MACHLEIDT C KUHLMANN U
Citation: T. Mettang et al., INTRADERMAL HEPATITIS-B VACCINATION IN NONRESPONSIVE HEMODIALYSIS-PATIENTS, Renal failure, 15(5), 1993, pp. 655-656
EPIDERMAL LANGERHANS CELLS IN UREMIC PATIENTS ON HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
Authors: METTANG T FRITZ P WEBER J MACHLEIDT C HUBEL E KIEFER T KUHLMANN U
Citation: T. Mettang et al., EPIDERMAL LANGERHANS CELLS IN UREMIC PATIENTS ON HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Nephron, 65(2), 1993, pp. 278-283
Risultati: 1-22 |